Treatment of high-grade glioma in children and adolescents
/in Dendritic Cells, Glioblastoma, International Publications /von 2011-07-22 / Neuro-oncology 2011 Oct;13(10):1049-58Route of administration modulates the induction of dendritic cell vaccine-induced antigen-specific T cells in advanced melanoma patients
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2011-07-19 / Clin. Cancer Res. 2011 Sep;17(17):5725-35Combinatorial strategies for alleviation of tumor-associated immune suppression and therapeutic vaccination against ovarian cancer
/in Dendritic Cells, International Publications, Ovarian Cancer /von 2011-07-01 / Immunotherapy 2011 Jul;3(7):805-7A phase I/II clinical trial investigating the adverse and therapeutic effects of a postoperative autologous dendritic cell tumor vaccine in patients with malignant glioma
/in Dendritic Cells, Glioblastoma, International Publications /von 2011-06-28 / J Clin Neurosci 2011 Aug;18(8):1048-54Prostate cancer immunotherapy
/in Dendritic Cells, International Publications, Prostate Cancer /von 2011-06-23 / Clin. Cancer Res. 2011 Aug;17(16):5233-8Dendritic cell (DC) vaccination with low dose temozolomide phase I/II trial in melanoma patients: Preliminary data on peripheral blood regulatory t-cells (Treg) and DC-TEM8 expression modulations.
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2011-06-17 / J Clin Oncol 29: 2011 (suppl; abstr e13029)Mature autologous dendritic cell vaccines in advanced non-small cell lung cancer: a phase I pilot study
/in Dendritic Cells, International Publications, NSCLC /von 2011-06-17 / J. Exp. Clin. Cancer Res. 2011 Jun;30:65Dendritic cells combining with cytokine-induced killer cells synergize chemotherapy in patients with late-stage non-small cell lung cancer
/in Dendritic Cells, International Publications, NSCLC /von 2011-06-17 / Cancer Immunol. Immunother. 2011 Oct;60(10):1497-502Sipuleucel-T: autologous cellular immunotherapy for men with asymptomatic or minimally symptomatic metastatic castrate resistant prostate cancer
/in Dendritic Cells, International Publications, Prostate Cancer /von 2011-06-15 / J Cancer 2011;2:357-9IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de